These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15171723)

  • 41. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.
    Zhang CC; Krieg S; Shapiro DJ
    Mol Endocrinol; 1999 Apr; 13(4):632-43. PubMed ID: 10194768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu.
    Benz CC; Scott GK; Sarup JC; Johnson RM; Tripathy D; Coronado E; Shepard HM; Osborne CK
    Breast Cancer Res Treat; 1992; 24(2):85-95. PubMed ID: 8095168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variant estrogen receptor-alpha messenger RNA expression in hormone-independent human breast cancer cells.
    Coutts AS; Leygue E; Murphy LC
    J Mol Endocrinol; 1999 Dec; 23(3):325-36. PubMed ID: 10601978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of BAG-1 expression alters the sensitivity of breast cancer cells to tamoxifen.
    Liu H; Lu S; Gu L; Gao Y; Wang T; Zhao J; Rao J; Chen J; Hao X; Tang SC
    Cell Physiol Biochem; 2014; 33(2):365-74. PubMed ID: 24557447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen receptor mutagenesis and hormone resistance.
    Fuqua SA
    Cancer; 1994 Aug; 74(3 Suppl):1026-9. PubMed ID: 8039136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo.
    Toi M; Harris AL; Bicknell R
    Br J Cancer; 1993 Dec; 68(6):1088-96. PubMed ID: 8260359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer.
    Lykkesfeldt AE
    Acta Oncol; 1996; 35 Suppl 5():9-14. PubMed ID: 9142958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
    Castles CG; Fuqua SA; Klotz DM; Hill SM
    Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of constitutively active Akt-3 in MCF-7 breast cancer cells reverses the estrogen and tamoxifen responsivity of these cells in vivo.
    Faridi J; Wang L; Endemann G; Roth RA
    Clin Cancer Res; 2003 Aug; 9(8):2933-9. PubMed ID: 12912939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.
    Brünner N; Boulay V; Fojo A; Freter CE; Lippman ME; Clarke R
    Cancer Res; 1993 Jan; 53(2):283-90. PubMed ID: 8380254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA; Sager R; Webster L
    Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Point mutation of estrogen receptor (ER) in the ligand-binding domain changes the pharmacology of antiestrogens in ER-negative breast cancer cells stably expressing complementary DNAs for ER.
    Jiang SY; Langan-Fahey SM; Stella AL; McCague R; Jordan VC
    Mol Endocrinol; 1992 Dec; 6(12):2167-74. PubMed ID: 1491696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines.
    Gomez BP; Riggins RB; Shajahan AN; Klimach U; Wang A; Crawford AC; Zhu Y; Zwart A; Wang M; Clarke R
    FASEB J; 2007 Dec; 21(14):4013-27. PubMed ID: 17660348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
    Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
    Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Both estradiol and tamoxifen decrease proliferation and invasiveness of cancer cells transfected with a mutated estrogen receptor.
    Garcia M; Derocq D; Platet N; Bonnet S; Brouillet JP; Touitou I; Rochefort H
    J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):11-7. PubMed ID: 9328205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.
    Saji S; Omoto Y; Shimizu C; Warner M; Hayashi Y; Horiguchi S; Watanabe T; Hayashi S; Gustafsson JA; Toi M
    Cancer Res; 2002 Sep; 62(17):4849-53. PubMed ID: 12208729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells.
    Yu Y; Zhou Q; Hang Y; Bu X; Jia W
    Cancer; 2007 Jun; 109(11):2374-82. PubMed ID: 17464948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.